Shengpeng Wang

4.7k total citations · 2 hit papers
94 papers, 3.7k citations indexed

About

Shengpeng Wang is a scholar working on Molecular Biology, Pharmacology and Complementary and alternative medicine. According to data from OpenAlex, Shengpeng Wang has authored 94 papers receiving a total of 3.7k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Molecular Biology, 22 papers in Pharmacology and 15 papers in Complementary and alternative medicine. Recurrent topics in Shengpeng Wang's work include Pharmacological Effects of Natural Compounds (12 papers), Traditional Chinese Medicine Analysis (8 papers) and RNA Interference and Gene Delivery (6 papers). Shengpeng Wang is often cited by papers focused on Pharmacological Effects of Natural Compounds (12 papers), Traditional Chinese Medicine Analysis (8 papers) and RNA Interference and Gene Delivery (6 papers). Shengpeng Wang collaborates with scholars based in Macao, China and United States. Shengpeng Wang's co-authors include Yitao Wang, Meiwan Chen, Yitao Wang, Ruie Chen, Xu Wu, Caifang Gao, Chi Teng Vong, Yangyang Hu, Zhangfeng Zhong and Anqi Wang and has published in prestigious journals such as Advanced Materials, PLoS ONE and Scientific Reports.

In The Last Decade

Shengpeng Wang

91 papers receiving 3.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Naturally occurring anti-cancer compounds: shining from Chinese herbal medicine

2019 412 citations Hua Luo, Chi Teng Vong et al. Chinese Medicine profile →
Astragali Radix (Huangqi): A promising edible immunomodulatory herbal medicine

2020 233 citations Zhejie Chen, Caifang Gao et al. profile →

Peers

Countries citing papers authored by Shengpeng Wang

Since Specialization

Citations

This map shows the geographic impact of Shengpeng Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shengpeng Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shengpeng Wang more than expected).

Fields of papers citing papers by Shengpeng Wang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shengpeng Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shengpeng Wang. The network helps show where Shengpeng Wang may publish in the future.

Co-authorship network of co-authors of Shengpeng Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Shengpeng Wang. A scholar is included among the top collaborators of Shengpeng Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shengpeng Wang. Shengpeng Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Reunderstanding the classical prescription Banxia Xiexin Decoction: new perspectives from a comprehensive review of clinical research and pharmacological studies 2025 ·Chinese Medicine ·Chang Liu, Ping Gao, Xiaoying Liu, Min Kuang, Haoran Xu, Yucai Wu, (unknown), Shengpeng Wang	2
2	Comparative analysis of Chinese classical prescriptions and global traditional polyherbal formulations: insights from the database of global polyherbal formulation (GPFD) 2025 ·Chinese Medicine ·Hongguo Chen, Zhaoyu Liu, (unknown), Xiangxiao Meng, Lian Xue, Xiang Sun, Zheng Xie, (unknown), (unknown), Ruo‐Lan Du, Jingwei Zhou, Ting Wang, (unknown), Shengpeng Wang	0
3	Nano-Based Drug Delivery Systems for Managing Diabetes: Recent Advances and Future Prospects 2025 ·International Journal of Nanomedicine ·Meihan Liu, Rui Wang, Maggie Pui Man Hoi, Yitao Wang, Shengpeng Wang, Ge Li, Chi Teng Vong, Cheong‐Meng Chong	4
4	CaCO3 nanoparticle-encapsulated CHA circuits for sensitive fluorescence detection of miRNA in living cells 2025 ·Journal of Colloid and Interface Science ·(unknown), Yu Yang, Hongyi Li, Jingqi Chen, (unknown), Fang Zhou, Yebin Xu, Shengpeng Wang	3
5	Ultraflexible Temperature‐Strain Dual‐Sensor Based on Chalcogenide Glass‐Polymer Film for Human‐Machine Interaction 2024 ·Advanced Materials ·Yanqing Fu, (unknown), (unknown), (unknown), Chengwei Gao, Linling Tan, (unknown), Shengpeng Wang, Zhuanghao Zheng, Shixun Dai, Changgui Lin	42
6	An enzyme-based system for extraction of small extracellular vesicles from plants 2023 ·Scientific Reports ·Qing Zhao, (unknown), Fubin Liu, (unknown), (unknown), Shengpeng Wang, (unknown), (unknown), Jiali Ye, Yue Cao, Lei Zheng, Kewei Zhao	16
7	Shikonin promotes ubiquitination and degradation of cIAP1/2-mediated apoptosis and necrosis in triple negative breast cancer cells 2021 ·Chinese Medicine ·Anqi Wang, Jiayu Liu, Yuhan Yang, Zhejie Chen, Caifang Gao, Zhanguo Wang, Chaomei Fu, Liang Zou, Shengpeng Wang	27
8	Correction to: West meets east: open up a dialogue on phytomedicine 2021 ·Chinese Medicine ·Xiuzhu Li, Weijie Chen, Jesús Simal‐Gándara, Milen I. Georgiev, Hongyi Li, Hao Hu, Xu Wu, (unknown), Shengpeng Wang	1
9	West meets east: open up a dialogue on phytomedicine 2021 ·Chinese Medicine ·Xiuzhu Li, Weijie Chen, Jesús Simal‐Gándara, Milen I. Georgiev, Hongyi Li, Hao Hu, Xu Wu, Thomas Efferth, Shengpeng Wang	17
10	Specific NLRP3 inflammasome inhibitors: promising therapeutic agents for inflammatory diseases 2021 ·Drug Discovery Today ·Chi Teng Vong, (unknown), Peifen Yao, Hua Yu, Shengpeng Wang, Zhangfeng Zhong, Yitao Wang	33
11	Reflections on treatment of COVID-19 with traditional Chinese medicine 2020 ·Chinese Medicine ·Hua Luo, Yan Gao, Jian Zou, Siyuan Zhang, Hanbin Chen, Qiao Liu, Dechao Tan, Yan Han, Yonghua Zhao, Shengpeng Wang	67
12	Chinese herb pair Paeoniae Radix Alba and Atractylodis Macrocephalae Rhizoma suppresses LPS-induced inflammatory response through inhibiting MAPK and NF-κB pathway 2019 ·Chinese Medicine ·Yangyang Zhou, Hongxun Tao, Anqi Wang, Zhangfeng Zhong, Xu Wu, Mei Wang, Zhaoxiang Bian, Shengpeng Wang, Yitao Wang	29
13	Novel drug delivery systems of Chinese medicine for the treatment of inflammatory bowel disease 2019 ·Chinese Medicine ·Caifang Gao, Li‐Juan Liu, Yangyang Zhou, Zhaoxiang Bian, Shengpeng Wang, Yitao Wang	37
14	Cupric ion functionalized polydopamine coated magnetic microspheres as solid-phase adsorbent for the extraction of purines in plasma 2019 ·Journal of Chromatography B ·Dong‐Dong Zhou, Qian Zhang, Hao Zhang, Yinzhen Wang, Feng Yang, Shengpeng Wang, Yitao Wang	6
15	Triphenylphosphonium-modified poly(ethylene glycol)-poly(ε-caprolactone) micelles for mitochondria- targeted gambogic acid delivery 2017 ·International Journal of Pharmaceutics ·Yingqi Xu, Shengpeng Wang, Hon Fai Chan, Yuling Liu, Hui Li, Chengwei He, (unknown), Meiwan Chen	46
16	Pluronic F68-Linoleic Acid Nano-spheres Mediated Delivery of Gambogic Acid for Cancer Therapy 2016 ·AAPS PharmSciTech ·Xiaobin Fang, Yingqi Xu, Shengpeng Wang, Jian‐Bo Wan, Chengwei He, Meiwan Chen	16
17	Berberine Regulated Lipid Metabolism in the Presence of C75, Compound C, and TOFA in Breast Cancer Cell Line MCF-7 2015 ·Evidence-based Complementary and Alternative Medicine ·Wen Tan, Zhangfeng Zhong, Shengpeng Wang, Zhan‐Wei Suo, Xian Yang, Xiao Hu, Yitao Wang	16
18	Oridonin Loaded Solid Lipid Nanoparticles Enhanced Antitumor Activity in MCF‐7 Cells 2014 ·Journal of Nanomaterials ·Lu Wang, Shengpeng Wang, Ruie Chen, Yanping Wang, Hui Li, Yitao Wang, Meiwan Chen	18
19	Enhancing the Antitumor Activity of Berberine Hydrochloride by Solid Lipid Nanoparticle Encapsulation 2014 ·AAPS PharmSciTech ·Lu Wang, Hong-Tao Li, Shengpeng Wang, Rong Liu, Zhisheng Wu, Chunming Wang, Yitao Wang, Meiwan Chen	93
20	Prokaryotic Expression of Bombyx mori Insulin-Related Peptide-Binding Protein 2 (BmIBP2) and Its Tissue-Specificity in Silkworm 2012 ·Zhongguo nongye Kexue ·Kun Gao, (unknown), (unknown), Shengpeng Wang, Heying Qian, (unknown)	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact